Sawgrass Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.55M | Sell |
11,714
-92
| -0.8% | -$20.4K | 0.38% | 53 |
|
|
2025
Q4 | $2.7M | Hold |
11,806
| – | – | 0.34% | 61 |
|
|
2025
Q3 | $2.73M | Sell |
11,806
-414
| -3% | -$84.3K | 0.34% | 58 |
|
|
2025
Q2 | $2.27M | Sell |
12,220
-50,376
| -80% | -$9.36M | 0.26% | 65 |
|
|
2025
Q1 | $13.1M | Sell |
62,596
-2,742
| -4% | -$533K | 1.61% | 14 |
|
|
2024
Q4 | $11.6M | Sell |
65,338
-3,597
| -5% | -$661K | 1.27% | 27 |
|
|
2024
Q3 | $13.6M | Sell |
68,935
-20,266
| -23% | -$3.78M | 1.42% | 25 |
|
|
2024
Q2 | $15.3M | Sell |
89,201
-554
| -0.6% | -$91.8K | 1.66% | 13 |
|
|
2024
Q1 | $16.3M | Sell |
89,755
-3,993
| -4% | -$688K | 1.79% | 13 |
|
|
2023
Q4 | $14.5M | Buy |
93,748
+19,136
| +26% | +$2.79M | 1.64% | 15 |
|
|
2023
Q3 | $11.1M | Sell |
74,612
-5,403
| -7% | -$793K | 1.35% | 22 |
|
|
2023
Q2 | $10.8M | Sell |
80,015
-64,091
| -44% | -$9.4M | 1.33% | 29 |
|
|
2023
Q1 | $23M | Sell |
144,106
-3,739
| -3% | -$572K | 2.98% | 6 |
|
|
2022
Q4 | $23.9M | Sell |
147,845
-3,128
| -2% | -$480K | 3.27% | 4 |
|
|
2022
Q3 | $20.3M | Buy |
150,973
+16,413
| +12% | +$2.36M | 2.9% | 5 |
|
|
2022
Q2 | $20.6M | Sell |
134,560
-86,782
| -39% | -$13.3M | 2.64% | 6 |
|
|
2022
Q1 | $35.9M | Buy |
+221,342
| New | +$32.2M | 3.76% | 4 |
|
|
2021
Q4 | – | Sell |
-221,192
| Closed | -$23.9M | – | 167 |
|
|
2021
Q3 | $23.9M | Sell |
221,192
-38,965
| -15% | -$4.45M | 2.42% | 7 |
|
|
2021
Q2 | $29.3M | Sell |
260,157
-81,785
| -24% | -$9.21M | 2.53% | 8 |
|
|
2021
Q1 | $37M | Buy |
341,942
+38,222
| +13% | +$4.09M | 2.98% | 6 |
|
|
2020
Q4 | $32.5M | Sell |
303,720
-5,778
| -2% | -$555K | 2.43% | 11 |
|
|
2020
Q3 | $27.1M | Buy |
309,498
+77,352
| +33% | +$7.28M | 2.15% | 14 |
|
|
2020
Q2 | $22.8M | Sell |
232,146
-20,189
| -8% | -$1.78M | 1.7% | 19 |
|
|
2020
Q1 | $19.2M | Sell |
252,335
-44,054
| -15% | -$3.75M | 1.72% | 16 |
|
|
2019
Q4 | $26.2M | Sell |
296,389
-5,196
| -2% | -$431K | 1.98% | 17 |
|
|
2019
Q3 | $22.8M | Sell |
301,585
-165,727
| -35% | -$11.4M | 1.77% | 22 |
|
|
2019
Q2 | $34M | Buy |
467,312
+25,800
| +6% | +$2.03M | 1.48% | 32 |
|
|
2019
Q1 | $35.6M | Buy |
441,512
+32,458
| +8% | +$2.66M | 1.59% | 26 |
|
|
2018
Q4 | $37.7M | Buy |
409,054
+28,134
| +7% | +$2.47M | 1.9% | 21 |
|
|
2018
Q3 | $36M | Buy |
380,920
+60,671
| +19% | +$5.75M | 1.53% | 29 |
|
|
2018
Q2 | $29.7M | Buy |
320,249
+9,032
| +3% | +$882K | 1.33% | 32 |
|
|
2018
Q1 | $29.5M | Sell |
311,217
-73,090
| -19% | -$8.03M | 1.41% | 29 |
|
|
2017
Q4 | $37.2M | Sell |
384,307
-208,100
| -35% | -$19.6M | 1.7% | 26 |
|
|
2017
Q3 | $52.6M | Sell |
592,407
-94,275
| -14% | -$7.18M | 2.57% | 9 |
|
|
2017
Q2 | $49.8M | Buy |
686,682
+167,235
| +32% | +$11.2M | 2.26% | 18 |
|
|
2017
Q1 | $33.8M | Buy |
519,447
+129,753
| +33% | +$8.16M | 1.54% | 31 |
|
|
2016
Q4 | $24.4M | Sell |
389,694
-10,110
| -3% | -$617K | 1.14% | 37 |
|
|
2016
Q3 | $25.2M | Sell |
399,804
-2,921
| -0.7% | -$189K | 1.17% | 33 |
|
|
2016
Q2 | $24.9M | Buy |
402,725
+97,885
| +32% | +$5.96M | 1.16% | 35 |
|
|
2016
Q1 | $17.4M | Buy |
304,840
+9,940
| +3% | +$554K | 0.8% | 39 |
|
|
2015
Q4 | $17.5M | Sell |
294,900
-285,882
| -49% | -$16.5M | 0.82% | 41 |
|
|
2015
Q3 | $31.6M | Sell |
580,782
-284,580
| -33% | -$18.5M | 1.55% | 31 |
|
|
2015
Q2 | $58.1M | Buy |
865,362
+12,160
| +1% | +$794K | 2.65% | 13 |
|
|
2015
Q1 | $49.9M | Buy |
853,202
+257,320
| +43% | +$15.5M | 2.29% | 15 |
|
|
2014
Q4 | $39M | Buy |
595,882
+107,140
| +22% | +$6.75M | 1.81% | 25 |
|
|
2014
Q3 | $28.2M | Buy |
488,742
+104,080
| +27% | +$5.78M | 1.65% | 28 |
|
|
2014
Q2 | $21.7M | Buy |
384,662
+90,750
| +31% | +$4.76M | 1.27% | 35 |
|
|
2014
Q1 | $15.1M | Sell |
293,912
-7,520
| -2% | -$380K | 0.92% | 43 |
|
|
2013
Q4 | $15.9M | Buy |
301,432
+17,062
| +6% | +$839K | 0.95% | 38 |
|
|
2013
Q3 | $12.7M | Sell |
284,370
-6,245
| -2% | -$277K | 0.89% | 39 |
|
|
2013
Q2 | $12M | Buy |
+290,615
| New | +$12.7M | 0.86% | 42 |
|
Other funds holding ABBV
VCM
VPM
Sawgrass Asset Management's ABBV Position: Q1 2026 in Review
Sawgrass Asset Management reduced its AbbVie (ABBV) stake by 0.78% in Q1 2026, selling an estimated $20.4K and leaving 11,714 shares worth $2.55M. The position accounts for 0.38% of the portfolio, ranked #53.
Sawgrass Asset Management first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $58.1M in Q2 2015. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Sawgrass Asset Management held 11,714 shares of AbbVie worth $2.55M as of Q1 2026.
- Sawgrass Asset Management sold 92 AbbVie shares in Q1 2026, an estimated $20.4K.
- AbbVie made up 0.38% of Sawgrass Asset Management's portfolio in Q1 2026, its #53 holding.
- Sawgrass Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- Sawgrass Asset Management's AbbVie position peaked at $58.1M in Q2 2015.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Sawgrass Asset Management's 13F filing for Q1 2026, filed 1 May 2026.